Alzheimer's disease Trials in Philadelphia, United States
Conditions / Alzheimer's disease / Philadelphia, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
68 total trials for this combination
Showing top 10 of 68 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00937352 | A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02956486 | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT00056524 | Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) | COMPLETED | PHASE3 |
| NCT04241068 | A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 | TERMINATED | PHASE3 |
| NCT01900665 | Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo | TERMINATED | PHASE3 |
| NCT05310071 | A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT00574132 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) | COMPLETED | PHASE3 |
| NCT06653153 | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02278367 | Clinical Evaluation of Flortaucipir F 18 | COMPLETED | PHASE2 |
| NCT03114657 | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) | TERMINATED | PHASE3 |